Milanowski, Janusz, Poland

• Vol 15, No 2 (2019) - CASE REPORT
  The effectiveness of chemotherapy in small cell lung cancer patients with BRCA2 gene mutation and Schwartz-Bartter syndrome
  Abstract  PDF
• Vol 19, No 3 (2023) - CASE REPORTS
  Replacement of ALK inhibitors as an effective strategy for reducing drug toxicity in non-small cell lung cancer patients with ALK gene rearrangement
  Abstract  PDF  HTML
• Vol 19, No 3 (2023) - CASE REPORTS
  Efficacy of chemoimmunotherapy in a lung adenocarcinoma patient with mutations in the KRAS and STK11
  Abstract  PDF  HTML
• Ahead of print - CASE REPORTS
  Tumor heterogeneity and its impact on sotorasib response in a patient with non-small cell lung cancer
  Abstract  PDF
• Ahead of print - ORIGINAL ARTICLES
  Unlocking the potential: the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) as biomarkers informing immunotherapy outcomes in lung cancer patients — single oncology center experience and literature review
  Abstract  PDF